论文部分内容阅读
目的:探讨子宫肌瘤剔除术后应用宫瘤消胶囊预防复发的疗效。方法:选择2007年1月～2009年1月行子宫肌瘤剔除术的患者,随机分为干预组和观察组,均于术前月经第三天采集静脉血,检测雌激素(E2)和孕激素(P)水平。干预组术后给予口服宫瘤消胶囊,3粒/次,3次/日,1个月经周期为1个疗程,连续服用3个疗程,观察组未给予特殊治疗,二者皆术后半年随访1次,共随访3年。以上两组患者均于术后3月、6月时月经第3天采血测E2和P水平。结果:干预组和观察组随诊过程中发现干预组的复发率明显低于观察组(P<0.05)。两组术前测得E2和P水平无统计学差异(P>0.05),术后3月测得E2和P水平有统计学差异(P<0.05),术后6月测得E2和P水平比较无统计学差异(P>0.05)。结论:宫瘤消胶囊应用于子宫肌瘤剔除术后对预防复发有积极作用。
Objective: To investigate the curative effect of Miu Miuxiao Capsule in preventing recurrence after uterine fibroids culling. Methods: Patients who underwent myomectomy from January 2007 to January 2009 were randomly divided into intervention group and observation group. Venous blood was collected on the third day of preoperative menstrual flow to detect estrogen (E2) and pregnancy Hormones (P) levels. The patients in the intervention group were treated with Gongwuxiao Capsule orally, 3 capsules / time, 3 times / day, 1 menstrual cycle for 1 course of treatment and 3 consecutive courses of treatment. The observation group was given no special treatment. Both were followed up for 6 months 1 times, a total of 3 years of follow-up. The above two groups of patients in the 3 months after surgery, 6 months menstrual blood test E2 and P levels. Results: The recurrence rate of intervention group and observation group was significantly lower than that of observation group (P <0.05). There was no significant difference in E2 and P levels between the two groups before operation (P> 0.05). There was a significant difference of E2 and P levels between March and March (P <0.05) No statistical difference (P> 0.05). Conclusion: Miyaumor capsule can be used in the prevention of recurrence after uterine fibroids have a positive effect.